Drug intelligence / Profile preview

DivertX

Development stage
Unknown
Lead developer
EviNature
Modality
Small Molecules
Administration
Oral
01

Overview

DivertX is an oral dietary supplement (nutraceutical) developed by EviNature in collaboration with gastroenterologists at Sheba Medical Center. It is a dual-action formula specifically designed to support gut health and manage diverticular disease, including diverticulitis and post-diverticulitis syndrome. The product contains two primary active ingredients: *Coptis chinensis* extract, which is rich in bioactive alkaloids such as berberine, palmatine, and jatrorrhizine, and a gut-directed 95% turmeric curcumin. DivertX works by strengthening the intestinal barrier, supporting the integrity of gut walls, and promoting microbial balance. Berberine from the *Coptis* extract stimulates the production of butyrate, a short-chain fatty acid essential for colonocyte health, while curcumin targets inflammatory pathways to facilitate tissue repair and reduce gut inflammation.

Brand names
DivertX
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)NF-κB

Beyond the preview

Go deeper on DivertX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DivertX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call